Literature DB >> 12200457

Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.

Ake Lundwall1, Anders Bjartell, A Yvonne Olsson, Johan Malm.   

Abstract

Semenogelin I (SgI) and semenogelin II (SgII) are the dominating protein components of the coagulum formed by freshly ejaculated human semen. The primary source of these proteins is the seminal vesicles and, apart from a small production of SgII in epididymis, they have not been detected in other tissues. In this report, we have re-examined the distribution of SgI and SgII transcripts and protein by RT-PCR and immunohistochemistry. Both SgI and SgII transcripts were demonstrated in several tissues, with the strongest signals coming from seminal vesicles, vas deferens, prostate, epididymis and trachea. Transcripts in the gastro-intestinal tract and skeletal muscle almost exclusively encoded SgI, whereas in kidney and testis, SgII transcripts were predominant. By immunohistochemistry, the basal cell layer of the secretory epithelium in prostate, trachea and bronchi was stained by antibodies recognizing both SgI and SgII. This is in contrast to the seminal vesicle and vas deferens, where the luminal cells were stained. The staining of skeletal muscle cells and a few scattered cells in the central nervous system suggests that semenogelin expression is not restricted to epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200457     DOI: 10.1093/molehr/8.9.805

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  29 in total

Review 1.  Contemporary evidence on the physiological role of reactive oxygen species in human sperm function.

Authors:  Stefan S Du Plessis; Ashok Agarwal; Jacques Halabi; Eva Tvrda
Journal:  J Assist Reprod Genet       Date:  2015-02-03       Impact factor: 3.412

2.  Semenogelin I expression in myeloma cells can be upregulated pharmacologically.

Authors:  Yana Zhang; Zhiqing Wang; Jian Zhang; Benjamin Farmer; Seah H Lim
Journal:  Leuk Res       Date:  2008-05-12       Impact factor: 3.156

3.  Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.

Authors:  Shengli Zhang; Jianzheng Fang; Xiangxiang Zhang; Chao Qin; Shifeng Su; Yunfei Deng; Zhen Song; Yi Zhang; Hainan Wang; Changjun Yin; Zengjun Wang
Journal:  Tumour Biol       Date:  2014-06-11

4.  Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity.

Authors:  Hitoshi Ishiguro; Koji Izumi; Eiji Kashiwagi; Yichun Zheng; Yi Li; Takashi Kawahara; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

5.  An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.

Authors:  Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2013-07

6.  Body fluid identification by mass spectrometry.

Authors:  Heyi Yang; Bo Zhou; Haiteng Deng; Mechthild Prinz; Donald Siegel
Journal:  Int J Legal Med       Date:  2013-03-24       Impact factor: 2.686

7.  Seminal Tract Amyloidosis: Synchronous Amyloidosis of the Seminal Vesicles, Deferent Ducts and Ejaculatory Ducts.

Authors:  Lea Rath-Wolfson; Golan Bubis; Shmuel Shtrasburg; Asaf Shvero; Rumelia Koren
Journal:  Pathol Oncol Res       Date:  2017-01-17       Impact factor: 3.201

8.  The evolution of a genetic locus encoding small serine proteinase inhibitors.

Authors:  Adam Clauss; Hans Lilja; Ake Lundwall
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

9.  An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.

Authors:  Yafei Hou; Jason DeVoss; Vinh Dao; Serena Kwek; Jeffrey P Simko; Douglas G McNeel; Mark S Anderson; Lawrence Fong
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  Semenogelins in the human retina: Differences in distribution and content between AMD and normal donor tissues.

Authors:  Vera L Bonilha; Mary E Rayborn; Karen G Shadrach; Yong Li; Ake Lundwall; Johan Malm; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2007-10-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.